Skip to main content
. 2009 Jul 31;10:42. doi: 10.1186/1471-2172-10-42

Figure 5.

Figure 5

Effect of IL-4 and IL-13 administration on the progression of the early stages of inflammation. No changes were observed in lipase activity in plasma or in MPO levels in pancreas. By contrast, a significant inhibition of MPO in lung and white adipose tissue (WAT) indicates a reduction of the systemic inflammation. * = p < 0.05 vs. control; + = p < 0.05 vs AP.

HHS Vulnerability Disclosure